Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient Outcomes.
about
Inflammatory breast cancer tumor emboli express high levels of anti-apoptotic proteins: use of a quantitative high content and high-throughput 3D IBC spheroid assay to identify targeting strategiesCDK4/6 and autophagy inhibitors synergistically induce senescence in Rb positive cytoplasmic cyclin E negative cancers.Heterogeneous perivascular cell coverage affects breast cancer metastasis and response to chemotherapyPatient-derived xenograft (PDX) models in basic and translational breast cancer research.Characterization of patient-derived tumor xenografts (PDXs) as models for estrogen receptor positive (ER+HER2- and ER+HER2+) breast cancers.Selinexor (KPT-330) demonstrates anti-tumor efficacy in preclinical models of triple-negative breast cancer.Correction: Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient Outcomes.A Population of Heterogeneous Breast Cancer Patient-Derived Xenografts Demonstrate Broad Activity of PARP Inhibitor in BRCA1/2 Wild-Type Tumors.Characterization of the effects of defined, multidimensional culture conditions on conditionally reprogrammed primary human prostate cells.Bridging the divide: preclinical research discrepancies between triple-negative breast cancer cell lines and patient tumors.
P2860
Q33688446-16FB19E0-0F97-4319-A498-C2F8851D3E0CQ33851230-CAD1F18D-905C-4200-9808-9332091C92A3Q37509823-C73159CB-2355-481D-89EF-878F6BBC5B80Q39057246-8AD3EB96-D412-4D7E-844F-634130817950Q39787293-F0F0C023-CB16-4D1B-BF75-A9D1FA03D431Q41412563-C0A77C9C-3B50-4307-B279-F513D2FA9B9FQ42666751-0D3A7777-1D40-4DCB-A5B5-40E3898E7766Q47577143-1827EBB5-0372-4F1A-B553-7DA72C8C0BAEQ49245661-9A891858-BAB9-4423-B5CA-C2E79326B9A8Q49619782-79F5902A-C361-4A62-B179-383BD36C9E6A
P2860
Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient Outcomes.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Ability to Generate Patient-De ...... redicts Poor Patient Outcomes.
@ast
Ability to Generate Patient-De ...... redicts Poor Patient Outcomes.
@en
type
label
Ability to Generate Patient-De ...... redicts Poor Patient Outcomes.
@ast
Ability to Generate Patient-De ...... redicts Poor Patient Outcomes.
@en
prefLabel
Ability to Generate Patient-De ...... redicts Poor Patient Outcomes.
@ast
Ability to Generate Patient-De ...... redicts Poor Patient Outcomes.
@en
P2093
P2860
P1433
P1476
Ability to Generate Patient-De ...... redicts Poor Patient Outcomes.
@en
P2093
Agda Karina Eterovic
Ana Maria Gonzalez-Angulo
Argun Akcakanat
Asha S Multani
Ashley M Holder
Aysegul Sahin
Chandeshwar Sharma
Dalliah M Black
Elizabeth A Mittendorf
Emily Tarco
P2860
P304
P356
10.1371/JOURNAL.PONE.0136851
P407
P577
2015-09-01T00:00:00Z